Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Ocular Surface Disease > Visual outcome and postop complications of cataract surgery in patients with OSD
  • Ocular Surface Disease

Visual outcome and postop complications of cataract surgery in patients with OSD

Ophthalmology 360

Cataract surgery outcome can be visually rewarding in patients with ocular surface disorders (OSD) provided ocular surface integrity is adequately maintained preoperatively and postoperatively, according to researchers of a recent retrospective observational study.

The study from a North India tertiary eye care center included 20 men and 24 women with various ocular surface disorders with stabilized ocular surfaces who underwent cataract surgery and had a minimum postop follow-up of 6 weeks. The primary outcome measures were post-operative best corrected visual acuity (BCVA) at 6 weeks, best BCVA and postoperative complications.

A total of 55 eyes were evaluated including 35 eyes with Steven-Johnson syndrome (SJS), 4 eyes with ocular cicatricial pemphigoid (OCP), 8 eyes with dry eye disease (DED), 6 eyes with chemical injury and 2 eyes with vernal keratoconjunctivitis (VKC). The mean duration of ocular surface disorder was 33.9 months. The median preoperative BCVA was 2.0. The median BCVA ever achieved was 0.50 at 2 months and the median BCVA at 6 weeks was 0.6. Maximum improvement in BCVA was observed in patients with DED and SJS and the least in OCP. Phacoemulsification was performed in 47.27% eyes with intraoperative complications noted in 9% eyes. Postoperative surface complications occurred in 12 (21.82%) eyes, while other postop complications occurred in 9 (16%) eyes.

Reference
Aggarwal M, Gour A, Gupta N, Singh A, Sangwan V. Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders. J Cataract Refract Surg. Published online January 16, 2024. doi:10.1097/j.jcrs.0000000000001396

Share

Related Content

  • Cataract

Cataract surgery linked to modest increase in neovascular AMD conversion risk

  • Ocular Surface Disease

Symptomatic MGD shows distinct age-related clinical patterns

  • Cataract

Cataract surgery complication rates unaffected by surgeon-patient sex concordance

  • Cataract

Optimizing cataract surgery outcomes through dry eye management

  • Cataract

Spotlight on TECNIS Odyssey™

  • Ocular Surface Disease

Scleral lenses improve vision and symptoms across ocular surface diseases

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon